Laniado Hospital, also known as the Sanz Medical Center, is a voluntary, not-for-profit hospital in Kiryat Sanz, Netanya, Israel, serving a regional population of over 450,000 in Netanya and the Sharon plain.

There are 484 beds in Laniado Hospital.

During the past decade, Laniado Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 4 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Laniado Hospital" #1 sponsor was "Laniado Hospital" with 6 trials, followed by "Bioverativ, a Sanofi company" with 2 trials sponsored, "Check-Cap Ltd." with 2 trials sponsored, "Rambam Health Care Campus" with 2 trials sponsored and "Smart Medical Systems Ltd." with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Laniado Hospital" #1 collaborator was "Laniado Hospital" with 3 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Carmel Medical Center" with 1 trials as a collaborator, "Dr. Jinna Weissman" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Laniado Hospital" are "Adenoma" (2 trials), "Colorectal Cancer" (2 trials), "Diffuse Large B-cell Lymphoma" (2 trials), "Agglutinin Disease, Cold" (1 trials) and "Agitation Related to Dementia" (1 trials). Many other conditions were trialed in "Laniado Hospital" in a lesser frequency.

Most popular intervention types in "Laniado Hospital" are "Drug" (11 trials), "Device" (5 trials), "Biological" (2 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "C-Scan System" (2 trials), "BGC101 (autologous EnEPC preparation)" (1 trials), "BIVV009" (1 trials), "Bendamustine" (1 trials) and "CPI 613, mFolfirinox" (1 trials). Other intervention names were less common.

The vast majority of trials in "Laniado Hospital" are 22 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Laniado Hospital". 1 are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Laniado Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Laniado Hospital, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".